Tyloxapol

N/A

Report date: 2025/07/24 17:42:00
NME

Base Information

Drug NameTyloxapol
Drug Alias NameSuperVent
ClassificationSmall molecules
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWindtree Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWindtree Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeR05CA01